IBS (International Blockchain Service) is a unique concept that allows users to design, operate, and host blockchain apps, functions, and smart contracts using cloud-based services. The platform offers fully functional blockchain platforms that make the development process more manageable. The vision of IBS is to enable blockchain to be accessible to as many individuals as possible worldwide. Furthermore, the platform intends to be a leading provider of secured digital services and possibilities and be the first platform to make digital products relevant to consumers' daily lives. 

IBS aims to create a set of global blockchain-based tools for service, education, NFT-based gaming, decentralized payment, DeFi, and decentralized exchange (DEX). The goal is to provide a highly secure and scalable infrastructure that enables smooth interchange between centralized and decentralized systems.

According to its whitepaper, IBS ecosystem provides blockchain token-based scholarships and maintains a database to track its students' achievements. Students receive token prizes from the network, exchangeable for digital products or services. Sponsorships and incentive distributions are also simplified with the usage of smart contracts. The IbsToken ecosystem aims to establish the world's first platform to enable token holders to participate in several upcoming blockchain-based projects. 

IBS is a TRC-20 utility token built on the TRON blockchain. TRC -20 is the TRON blockchain's technical standard for smart contracts. TRON is a blockchain-based operating system that is decentralized and open source. As a utility token, IBS allows users across the globe to access a range of digital products and offers discounts and loyalty benefits to encourage consumers to use the platform. 

The IBSToken platform was launched by IBSA PVT. LTD. in Februaury 2020. The token’s total supply stands at 1,500,000,000 IBS. 

我们实时将 IBStoken 更新为 USD 货币。通过 Coinbase 获取最新 IBStoken 价格。

与IBStoken具有相似市值的资产包括BitForex Token, Flying Tulip, Grin和许多其他资产。要查看完整列表，请参阅我们的可比市值资产。